Avalo Therapeutics (AVTX) CFO Sullivan Sells $1.4M in Stock

Avalo Therapeutics CFO, Sullivan, sold over $1.4 million in company stock, highlighting potential insider movements. The transaction could signal changes in confidence among corporate insiders. Such actions may impact investor sentiment and market perception of Avalo Therapeutics (AVTX). Investors often scrutinize insider trading as it may indicate a company's outlook.